New York: Hydroxychloroquine drug was tested on 1376 patients with coronavirus infection in New York, USA. This is the same thing that many countries requested from India. However, in this research, it has been found that there is no significant improvement in the health of the patients who eat hydroxychloroquine, on the contrary, their health worsens further.
WHO warns, 'economic activities can worsen situation'
In this research conducted on 1376 patients, about 60% of the patients were given hydroxychloroquine and the remaining patients were not given this medicine. Then the health of both the patients was studied. This research has been published by the New England Journal of Medicine. However, this medicine is still being given to patients in many hospitals in India. We also have to see that the US is offering the Gilliard company's Remedicivir drug as a treatment for the coronavirus.
Death of 5-year-old child in New York remains mystery, know complete matter
Many countries are talking about their medicines. It is necessary to look at this research in a global perspective on the question of hydroxychloroquine. However, there has been no announcement from the WHO regarding Corona's drug so far. Research is going on around the world.
Firing in Afghanistan amidst ongoing demonstration on economic demand